文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

机械通气的2019冠状病毒病患者28天院内死亡率评估:一项国际队列研究

Assessment of 28-Day In-Hospital Mortality in Mechanically Ventilated Patients With Coronavirus Disease 2019: An International Cohort Study.
PubMed 文献 · Crit Care Explor · 2021-11-05
一句话结论国际队列显示,机械通气的COVID-19患者中年龄较大及基线或动态监测的临床指标(肌酐、乳酸、Paco2、pH、PaO2/FiO2、平均动脉压)与28天死亡风险相关。

该研究为全球COVID-19重症监护联盟的前瞻性观察性队列,纳入2020年2月2日至2021年5月15日实验室确诊、需有创机械通气的COVID-19患者。在1587例生存分析患者中,588例(37%)在开始有创机械通气后28天内院内死亡。Cox回归显示,年龄(每增加10岁HR 1.26,95%CI 1.16-1.37,p<0.001)和初始呼气末正压(每增加5 cm H2O HR 0.81,95%CI 0.67-0.97,p=0.02)与28天死亡风险相关;时间依赖变量血清肌酐、乳酸、Paco2、pH、PaO2/FiO2和平均动脉压亦与风险相关。作者认为需进一步研究验证这些参数的因果作用。

要点

  • 1587例机械通气COVID-19患者中,588例(37%)在开始有创机械通气后28天内院内死亡。
  • 年龄每增加10岁,28天死亡风险HR 1.26(95%CI 1.16-1.37,p<0.001)。
  • 开始有创机械通气时呼气末正压每增加5 cm H2O,28天死亡风险HR 0.81(95%CI 0.67-0.97,p=0.02)。
  • 时间依赖变量中,血清肌酐每翻倍HR 1.28(95%CI 1.15-1.41,p<0.001),乳酸每翻倍HR 1.22(95%CI 1.11-1.34,p<0.001),Paco2每翻倍HR 1.63(95%CI 1.19-2.25,p<0.001)。
  • PaO2/FiO2每翻倍HR 0.58(95%CI 0.52-0.66,p<0.001),平均动脉压每增加10 mm Hg HR 0.92(95%CI 0.88-0.97,p=0.003)。

适用人群与场景

  • 2020年2月2日至2021年5月15日期间,全球COVID-19重症监护联盟纳入的实验室确诊COVID-19、需要有创机械通气的患者。
  • 患者特征与临床数据在ICU入院时、开始有创机械通气时及此后28天内评估。

研究设计与关键结果

  • 研究设计:全球COVID-19重症监护联盟的前瞻性观察性队列研究。
  • 共1587例患者纳入生存分析,其中588例(37%)在开始有创机械通气后28天内院内死亡。
  • Cox回归显示,年龄每增加10岁与28天有创机械通气死亡风险相关(HR 1.26,95%CI 1.16-1.37,p<0.001)。
  • 开始有创机械通气时呼气末正压每增加5 cm H2O与28天死亡风险相关(HR 0.81,95%CI 0.67-0.97,p=0.02)。
  • 时间依赖参数中,血清肌酐每翻倍HR 1.28(95%CI 1.15-1.41,p<0.001),乳酸每翻倍HR 1.22(95%CI 1.11-1.34,p<0.001),Paco2每翻倍HR 1.63(95%CI 1.19-2.25,p<0.001)。
  • 时间依赖参数中,pH每增加0.1 HR 0.89(95%CI 0.8-14,p=0.041),PaO2/FiO2每翻倍HR 0.58(95%CI 0.52-0.66,p<0.001),平均动脉压每增加10 mm Hg HR 0.92(95%CI 0.88-0.97,p=0.003)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究。
  • 局限:作者指出需进一步研究以验证这些参数对临床结局可能存在的因果作用。

对床旁实践的改变

  • 作者认为,在机械通气的COVID-19患者中,年龄较大以及基线或机械通气过程中动态监测的临床相关变量与28天有创机械通气死亡风险相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Factors associated with mortality in coronavirus disease 2019 patients on invasive mechanical ventilation are still not fully elucidated.

OBJECTIVES: To identify patient-level parameters, readily available at the bedside, associated with the risk of in-hospital mortality within 28 days from commencement of invasive mechanical ventilation or coronavirus disease 2019.

DESIGN SETTING AND PARTICIPANTS: Prospective observational cohort study by the global Coronavirus Disease 2019 Critical Care Consortium. Patients with laboratory-confirmed coronavirus disease 2019 requiring invasive mechanical ventilation from February 2, 2020, to May 15, 2021.

MAIN OUTCOMES AND MEASURES: Patient characteristics and clinical data were assessed upon ICU admission, the commencement of invasive mechanical ventilation and for 28 days thereafter. We primarily aimed to identify time-independent and time-dependent risk factors for 28-day invasive mechanical ventilation mortality.

RESULTS: One-thousand five-hundred eighty-seven patients were included in the survival analysis; 588 patients died in hospital within 28 days of commencing invasive mechanical ventilation (37%). Cox-regression analysis identified associations between the hazard of 28-day invasive mechanical ventilation mortality with age (hazard ratio, 1.26 per 10-yr increase in age; 95% CI, 1.16-1.37; p < 0.001), positive end-expiratory pressure upon commencement of invasive mechanical ventilation (hazard ratio, 0.81 per 5 cm H2O increase; 95% CI, 0.67-0.97; p = 0.02). Time-dependent parameters associated with 28-day invasive mechanical ventilation mortality were serum creatinine (hazard ratio, 1.28 per doubling; 95% CI, 1.15-1.41; p < 0.001), lactate (hazard ratio, 1.22 per doubling; 95% CI, 1.11-1.34; p < 0.001), Paco2 (hazard ratio, 1.63 per doubling; 95% CI, 1.19-2.25; p < 0.001), pH (hazard ratio, 0.89 per 0.1 increase; 95% CI, 0.8-14; p = 0.041), Pao2/Fio2 (hazard ratio, 0.58 per doubling; 95% CI, 0.52-0.66; p < 0.001), and mean arterial pressure (hazard ratio, 0.92 per 10 mm Hg increase; 95% CI, 0.88-0.97; p = 0.003).

CONCLUSIONS AND RELEVANCE: This international study suggests that in patients with coronavirus disease 2019 on invasive mechanical ventilation, older age and clinically relevant variables monitored at baseline or sequentially during the course of invasive mechanical ventilation are associated with 28-day invasive mechanical ventilation mortality hazard. Further investigation is warranted to validate any causative roles these parameters might play in influencing clinical outcomes.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Li Bassi G, Suen JY, White N, et al. Assessment of 28-Day In-Hospital Mortality in Mechanically Ventilated Patients With Coronavirus Disease 2019: An International Cohort Study. Crit Care Explor. 2021. PMID: 34765979. doi:10.1097/CCE.0000000000000567

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。